ES466774A1 - Procedimiento para la obtencion de homo- o copolimeros hi- drosolubles de efecto antitumoral - Google Patents

Procedimiento para la obtencion de homo- o copolimeros hi- drosolubles de efecto antitumoral

Info

Publication number
ES466774A1
ES466774A1 ES466774A ES466774A ES466774A1 ES 466774 A1 ES466774 A1 ES 466774A1 ES 466774 A ES466774 A ES 466774A ES 466774 A ES466774 A ES 466774A ES 466774 A1 ES466774 A1 ES 466774A1
Authority
ES
Spain
Prior art keywords
composition
tumoral agents
tumours
urethanes
intramuscularly
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES466774A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19772705189 external-priority patent/DE2705189C2/de
Priority claimed from DE19772740081 external-priority patent/DE2740081A1/de
Priority claimed from DE19772740082 external-priority patent/DE2740082A1/de
Application filed by Bayer AG filed Critical Bayer AG
Publication of ES466774A1 publication Critical patent/ES466774A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES466774A 1977-02-08 1978-02-08 Procedimiento para la obtencion de homo- o copolimeros hi- drosolubles de efecto antitumoral Expired ES466774A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19772705189 DE2705189C2 (de) 1977-02-08 1977-02-08 Antitumoral wirkende Mittel
DE19772740081 DE2740081A1 (de) 1977-09-06 1977-09-06 Antitumoral wirkende mittel
DE19772740082 DE2740082A1 (de) 1977-09-06 1977-09-06 Antitumoral wirkende mittel

Publications (1)

Publication Number Publication Date
ES466774A1 true ES466774A1 (es) 1979-06-01

Family

ID=27187112

Family Applications (1)

Application Number Title Priority Date Filing Date
ES466774A Expired ES466774A1 (es) 1977-02-08 1978-02-08 Procedimiento para la obtencion de homo- o copolimeros hi- drosolubles de efecto antitumoral

Country Status (7)

Country Link
JP (1) JPS5399334A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) AT362146B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (1) CH633963A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES466774A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2379286A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB1569962A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL175968C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3265603D1 (en) * 1981-06-17 1985-09-26 Monsanto Co Co- and ter-polymers of alkyl- and chloroalkyl vinyl ethers, maleic anhydride and maleimide having antitumor activity
DE3572985D1 (en) * 1984-05-11 1989-10-19 Bristol Myers Co Novel bile sequestrant resin and uses
US4649048A (en) * 1984-05-11 1987-03-10 Bristol-Myers Company Novel bile sequestrant resin
US4604430A (en) * 1984-05-11 1986-08-05 Bristol-Myers Company Novel bile sequestrant resin
DE3727082A1 (de) * 1987-08-14 1989-02-23 Goedecke Ag Pharmazeutische zubereitungen zur behandlung der urolithiasis
JP6110678B2 (ja) * 2012-02-10 2017-04-05 株式会社クラレ ヒドロキシメチル基含有ビニルアルコール系重合体
JP5971174B2 (ja) * 2013-03-29 2016-08-17 株式会社クラレ 燃料容器
US9663592B2 (en) 2012-08-09 2017-05-30 Kuraray Co., Ltd. Modified ethylene-vinyl alcohol copolymer, method for producing same, and use of same
JP6045112B2 (ja) * 2012-08-09 2016-12-14 株式会社クラレ 共射出延伸ブロー成形容器
JP5909811B2 (ja) * 2012-08-09 2016-04-27 株式会社クラレ 変性エチレン−ビニルアルコール共重合体及び多層構造体
JP5971173B2 (ja) * 2013-03-29 2016-08-17 株式会社クラレ 熱収縮フィルム
CN105683264B (zh) * 2013-08-09 2019-04-16 株式会社可乐丽 膜
JP6207921B2 (ja) * 2013-08-09 2017-10-04 株式会社クラレ ビニルアセタール系重合体
JP6177045B2 (ja) * 2013-08-09 2017-08-09 株式会社クラレ 変性エチレン−ビニルアルコール共重合体からなる複合繊維
WO2015020220A1 (ja) * 2013-08-09 2015-02-12 株式会社クラレ 水性エマルジョン組成物、接着剤、水性エマルジョン組成物の製造方法、乳化重合用安定剤及び接着剤の製造方法
JP6254381B2 (ja) * 2013-08-09 2017-12-27 株式会社クラレ ビニルアセタール系重合体を含有するフィルム
WO2015020046A1 (ja) * 2013-08-09 2015-02-12 株式会社クラレ ビニルアルコール系重合体フィルム
JP6383664B2 (ja) * 2013-08-09 2018-08-29 株式会社クラレ 光学フィルム製造用原反フィルム
JP6184799B2 (ja) * 2013-08-09 2017-08-23 株式会社クラレ 変性エチレン−ビニルアルコール共重合体からなる繊維
JP6554702B2 (ja) * 2014-01-31 2019-08-07 株式会社クラレ エチレン−ビニルアルコール共重合体樹脂組成物及びその製造方法
JP6218177B2 (ja) * 2014-02-12 2017-10-25 株式会社クラレ 樹脂組成物及びその製造方法

Also Published As

Publication number Publication date
JPS6136494B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1986-08-19
FR2379286B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1980-08-29
NL175968B (nl) 1984-09-03
GB1569962A (en) 1980-06-25
NL175968C (nl) 1985-02-01
NL7801402A (nl) 1978-08-10
CH633963A5 (en) 1983-01-14
JPS5399334A (en) 1978-08-30
AT362146B (de) 1981-04-27
ATA86678A (de) 1980-09-15
FR2379286A1 (fr) 1978-09-01

Similar Documents

Publication Publication Date Title
ES466774A1 (es) Procedimiento para la obtencion de homo- o copolimeros hi- drosolubles de efecto antitumoral
KR920002144A (ko) 아연 l-카르노신 염 또는 이의 착화합물을 유효성분으로 함유하는 염증성 장질환 예방 및 치료제
ES2105926B1 (es) El uso de taxol para la fabricacion de una preparacion de infusion para el tratamiento del cancer.
IL49229A (en) Poly(2,2,6,6-tetra-alkyl-4-piperidyl)-amines,their preparation and their use as stabilizers for polyolefin compositions
MXPA02002681A (es) Uso de metabolitos de acido alfa-linolenico para el tratamiento o prevencion del cancer.
SE7611379L (sv) Antihypertensiva medel
DE60143911D1 (de) Antitumorzusammensetzungen welche ecteinascidin 743 enthalten
KR0156587B1 (en) Composition for therapeutic agent against chronic viral hepatic disease
GR3017855T3 (en) Use of lithium in the treatment or prophylaxis of Molluscum contagiosum.
ES2087915T3 (es) Agente terapeutico y procedimiento que inhibe la vascularizacion de tumores.
SE7601535L (sv) Injicerbara antibiotiska kompositioner
IE781550L (en) Bis-(tetrahydroisoquinolinium) salt; neuromuscular blocking¹agent
FR2407717A1 (fr) Usage therapeutique nouveau de l'acetyl-1-carnitine
GB1270049A (en) New pharmaceutical product
Bailey Oral Berenil in the treatment and prophylaxis of human trypanosomiasis
KR930702984A (ko) 비-소세포 폐암의 치료
Chang Clinical aspects of hyperbaric oxygen and radiotherapy
GB1507643A (en) 4-(5-nitro-2-furyl)quinaldinic acid n-oxide and its use in the treatment of bovine mastitis
IL98200A0 (en) Pharmaceutical composition containing a derivative of substituted-l-valyl-l-prolinamide
JPS5170769A (en) 10*111 jihidoro 33 karubokishishipuroheputajin oyobi sono nn okisaido
Selawry et al. Methotrexate in Leukemia Intramuscularly-Reply
JPS55122721A (en) Antidiabetic agent
USD214504S (en) Dental cabinet or the like
USD158695S (en) Hydraulic jack
USD211345S (en) Dental console

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19990503